在状细胞病患者的ERAS项目的元素中进行未来研究的新型机制模型
Marcy Purnell1, Michong Rayborn2
1is a Graduate Program Chair and Associate Professor, Baptist Health Sciences University, Memphis, Tennessee.
AANA journal
|April 2, 2024
概括
在手术后改善恢复 (ERAS) 协议可能需要对状细胞病患者进行调整. 新兴研究表明,对葡萄糖和离子度的独特反应可能会影响血管封闭性危机.
科学领域:
- 在外科手术期间的医学.
- 血液学 血液学 血液学
- 手术重症监护手术重症监护
背景情况:
- 手术后增强恢复 (ERAS) 是一种以患者为中心的方法,以优化手术结果.
- 现有的ERAS指南并没有专门解决状细胞病 (SCD) 患者的独特需求.
- SCD患者可能对外科手术期间的流体和营养管理有不同的反应.
研究的目的:
- 评估在状细胞病患者中修改ERAS协议的潜在需求.
- 探索一种新的机械模型,影响周围手术的管理策略.
- 为了确定与目前的ERAS对SCD患者的建议相关的风险.
主要方法:
- 审查当前的ERAS指南和有关SCD病理生理学的相关文献.
- 对一种新的机制模型的分析,该模型将血清葡萄糖/离子度与SCD中的红细胞功能联系起来.
- 检查actin和血红蛋白糖化在SCD相关不良反应中的作用.
主要成果:
- 新兴研究表明,SCD患者可能对高血糖和高血压状态产生不良反应.
- 增加血红蛋白糖化可能会损害红细胞的活性功能.
- 这种损伤可能会在外科手术期间在SCD患者中导致血管闭塞危机.
结论:
- 目前的ERAS协议可能需要对状细胞病患者进行修改.
- 一个新的机械模型强调了定制的外科手术管理的必要性.
- 需要进一步的研究来开发基于证据的ERASSSCD协议,重点关注风险减轻.
更多相关视频
08:53Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
Published on: January 10, 2025
475
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
1.7K
相关概念视频
01:23Mechanistic Models: Compartment Models in Individual and Population Analysis
39
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
39
01:49Multiple Allele Traits
34.2K
The Concept of Multiple Allelism
34.2K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K